MARKET

VIVS

VIVS

VivoSim Labs Inc
NASDAQ
0.4189
-0.0311
-6.91%
After Hours: 0.3990 -0.0199 -4.75% 19:58 07/24 EDT
OPEN
0.4460
PREV CLOSE
0.4500
HIGH
0.4477
LOW
0.4100
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
5.30
52 WEEK LOW
0.4100
MARKET CAP
1.46M
P/E (TTM)
-0.0783
1D
5D
1M
3M
1Y
5Y
1D
VivoSim Labs Addresses Nasdaq Listing Compliance Concerns
TipRanks · 14h ago
VivoSim Labs Receives Nasdaq Noncompliance Notice, Gets Time Through Sept. 3 To Regain Compliance
Benzinga · 15h ago
VivoSim Labs faces Nasdaq delisting risk after falling below $2.5 million stockholders’ equity requirement
PUBT · 15h ago
VivoSim enters China with first commercial sales of NAMkind testing services
TipRanks · 3d ago
VivoSim Labs Announces First Commercial Sales In China For Its NAMkind Testing Services
Benzinga · 3d ago
VivoSim logs first China commercial orders for NAMkind GI toxicology, efficacy testing services
PUBT · 3d ago
Weekly Report: what happened at VIVS last week (0713-0717)?
Weekly Report · 5d ago
VivoSim Labs Announces $4 Million Private Placement Financing
TipRanks · 07/17 13:17
More
About VIVS
VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company, which is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company also advances product candidates to treat inflammatory bowel disease (IBD) discovered and developed using its complex human tissue intestinal models.

Webull offers VivoSim Labs Inc stock information, including NASDAQ: VIVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIVS stock methods without spending real money on the virtual paper trading platform.